A research roundup summarized three recent studies examining cardiovascular outcomes, treatment withdrawal effects, and comparative risk reduction associated with semaglutide and tirzepatide.
This article summarizes recent research on the cardiovascular effects of semaglutide and tirzepatide for cardiac nursing practice.
In this month's Research Roundup presented by the British Association of Nursing in Cardiovascular Care (BANCC), Robyn Lotto, Sarah McSharry and Rosetta Binu summarise three recent research studies examining cardiovascular outcomes, treatment withdrawal effects, and comparative risk reduction associated with semaglutide and tirzepatide. The implications for cardiac nursing practice are discussed and a full reference is provided for those who wish to explore the evidence in more detail.
McSharry et al. (Sat,) conducted a review in Cardiovascular outcomes. Semaglutide and tirzepatide was evaluated. A research roundup summarized three recent studies examining cardiovascular outcomes, treatment withdrawal effects, and comparative risk reduction associated with semaglutide and tirzepatide.